| 127 |
Dong-A ST Files New Drug Application for Combination Diabetes Treatment Sugadapamet XR Tab |
2023-04-18 |
| 126 |
Dong-A ST Applies for FDA Phase 2 IND Approval for NeuroBo’s NASH Drug DA-1241 |
2023-04-17 |
| 125 |
Dong-A ST Holds 10th Annual General Shareholders' Meeting |
2023-04-17 |
| 124 |
Dong-A ST Provides Growth Hormone Support for Children with Short Stature |
2023-04-17 |
| 123 |
Dong-A ST Participates in the Modong Forest Creation Project in Yeoncheon, Gyeonggi-do Province |
2023-04-06 |
| 122 |
Dong-A CHAMMED, a Subsidiary of Dong-A ST, to Merge with MH Healthcare |
2023-02-03 |
| 121 |
Dong-A ST Signs Licensing Agreement with Mezoo for Remote ECG Monitoring Platform "HiCardi" |
2023-02-01 |
| 120 |
Dong-A ST Launches Hepatitis B Drug, Vemlia |
2023-02-01 |
| 119 |
Dong-A ST Renews Co-Promotion Agreement with Celltrion for Hypertension Treatments Edarbi and Edarbyclor |
2023-01-19 |
| 118 |
Dong-A ST Demonstrates Equivalence in Global Phase 3 Trial for Stelara Biosimilar DMB-3115 |
2023-01-16 |
